• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,664.21 -999.79
( -1.29%)
Global Indices
Nasdaq
49,330.80 -180.24
(-0.36%)
Dow Jones
7,129.46 -29.44
(-0.41%)
Hang Seng
59,744.07 603.84
(1.02%)
Nikkei 225
10,468.22 -8.24
(-0.08%)
Forex
USD-INR
93.75 0.31
(0.34%)
EUR-INR
109.98 0.10
(0.09%)
GBP-INR
126.66 0.42
(0.33%)
JPY-INR
0.59 0.00
(0.23%)

EQUITY - MARKET SCREENER

Titan Biotech Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524717
INE150C01029
37.8863463
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
82.26
2029.15
EPS(TTM)
Face Value()
Div & Yield %
5.97
2
0.08
 

Mazda spurts as Q3 PAT climbs 18% YoY to Rs 9 cr
Feb 12,2026

Revenue from operations rose 1.30% to Rs 47.39 crore during the quarter, compared with Rs 46.78 crore in the same quarter last year.

Profit from operations before tax stood at Rs 11.29 crore in Q3 FY26, up 16.39%, compared with Rs 9.70 crore recorded in the same quarter last year.

The company's revenue from engineering division rose 2.52% YoY to Rs 40.14 crore in Q3 FY26, while revenue from food division decreased 4.98% YoY to Rs 7.24 crore.

Mazda is engaged in the business of manufacturing Engineering goods like Vacuum Products, Evaporators, Pollution Control Equipments and Manufacturing of Food Products like Food colour, Various Fruit Jams & Fruit mix Powders etc.